$7.28
4.75% yesterday
Nasdaq, Sep 23, 10:00 pm CET
ISIN
US0088751062
Symbol
DOMH

AIkido Pharma Inc Stock price

$7.28
+1.29 21.50% 1M
+1.99 37.65% 6M
+6.37 698.86% YTD
+5.47 303.28% 1Y
+0.94 14.80% 3Y
-1.42 16.35% 5Y
-430.92 98.34% 10Y
-368,433.13 100.00% 20Y
Nasdaq, Closing price Tue, Sep 23 2025
+0.33 4.75%
ISIN
US0088751062
Symbol
DOMH
Industry

Key metrics

Basic
Market capitalization
$108.0m
Enterprise Value
$79.8m
Net debt
positive
Cash
$28.2m
Shares outstanding
15.2m
Valuation (TTM | estimate)
P/E
negative | -
P/S
2.0 | -
EV/Sales
1.5 | -
EV/FCF
negative
P/B
1.2
Financial Health
Equity Ratio
84.6%
Return on Equity
-36.9%
ROCE
-61.9%
ROIC
-
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$52.8m | -
EBITDA
$-57.3m | -
EBIT
$-57.4m | -
Net Income
$-19.0m | -
Free Cash Flow
$-7.1m
Growth (TTM | estimate)
Revenue
455.3% | -
EBITDA
-298.6% | -
EBIT
-296.3% | -
Net Income
13.6% | -
Free Cash Flow
54.6%
Margin (TTM | estimate)
Gross
-
EBITDA
-108.5% | -
EBIT
-108.7%
Net
-36.0% | -
Free Cash Flow
-13.4%
More
EPS
$-1.3
FCF per Share
$-0.5
Short interest
6.2%
Employees
29
Rev per Employee
$630.0k
Show more

Is AIkido Pharma Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,013 stocks worldwide.

AIkido Pharma Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

6x Buy
86%
1x Hold
14%

Analyst Opinions

7 Analysts have issued a AIkido Pharma Inc forecast:

Buy
86%
Hold
14%

Financial data from AIkido Pharma Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
53 53
455% 455%
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 110 110
359% 359%
209%
- Research and Development Expense - -
-
-
-57 -57
299% 299%
-109%
- Depreciation and Amortization 0.11 0.11
0% 0%
0%
EBIT (Operating Income) EBIT -57 -57
296% 296%
-109%
Net Profit -19 -19
14% 14%
-36%

In millions USD.

Don't miss a Thing! We will send you all news about AIkido Pharma Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

AIkido Pharma Inc Stock News

Neutral
PRNewsWire
about 10 hours ago
NEW YORK , Sept. 23, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH), today announced that Tim Ledwick, a current member of the Company's Board of Directors, has stepped down from the Board to serve as Interim Chief Financial Officer, beginning October 1, 2025.
Neutral
PRNewsWire
13 days ago
Accomplished entrepreneur and global speaker to strengthen firm's marketing, investor engagement and strategic communications to help drive growth NEW YORK , Sept. 10, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH), today announced the appointment of Brian Parsley to its Board of Directors.
Neutral
PRNewsWire
14 days ago
Dominari Holdings Inc. Holds Approximately 23,199,205 Shares of American Bitcoin (NASDAQ: ABTC), Valued at Approximately $170 Million at ABTC's September 5, 2025 Close NEW YORK , Sept. 9, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) ("Dominari" or the "Company") (NASDAQ: DOMH) today congratulated American Bitcoin ("ABTC") on its successful listing on the Nasdaq Stock Market.
More AIkido Pharma Inc News

Company Profile

Spherix Incorporated, a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. Its pipeline of therapeutics includes therapies for pancreatic cancer, acute myeloid leukemia, and acute lymphoblastic leukemia. The company's platform consists of patented technology from leading universities and researchers and in the process of developing an innovative therapeutic drug platform through partnerships with world renowned educational institutions, including The University of Texas at Austin and Wake Forest University. It has a scientific research agreement with The University of Texas Southwestern Medical Center to use machine learning to find genetic markers in people that indicate an increased risk of developing pancreatic cancer. Spherix Incorporated was founded in 1967 and is based in New York, New York.

Head office United States
CEO Anthony Hayes
Employees 29
Founded 1967
Website www.dominariholdings.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today